 Karin Zemski Berry
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 5 | 2026 | 643 | 1.680 |
Why?
| | Phospholipids | 9 | 2024 | 214 | 1.670 |
Why?
| | Muscle, Skeletal | 6 | 2026 | 1788 | 1.470 |
Why?
| | Insulin Resistance | 9 | 2026 | 1241 | 1.360 |
Why?
| | Weight Loss | 2 | 2026 | 839 | 1.250 |
Why?
| | Phosphatidylethanolamines | 5 | 2013 | 76 | 1.160 |
Why?
| | Ceramides | 4 | 2024 | 117 | 0.940 |
Why?
| | Phosphatidylcholines | 4 | 2024 | 130 | 0.940 |
Why?
| | Obesity | 10 | 2026 | 3070 | 0.940 |
Why?
| | Lipid Metabolism | 3 | 2026 | 524 | 0.930 |
Why?
| | Sarcolemma | 1 | 2024 | 35 | 0.850 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2017 | 141 | 0.850 |
Why?
| | Exercise | 2 | 2026 | 2183 | 0.810 |
Why?
| | Lipids | 6 | 2022 | 706 | 0.720 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 7 | 2016 | 179 | 0.630 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2573 | 0.590 |
Why?
| | Placenta | 6 | 2026 | 781 | 0.580 |
Why?
| | Docosahexaenoic Acids | 5 | 2024 | 83 | 0.570 |
Why?
| | Arachidonate 5-Lipoxygenase | 2 | 2016 | 37 | 0.560 |
Why?
| | Tandem Mass Spectrometry | 6 | 2024 | 565 | 0.550 |
Why?
| | Plasmalogens | 3 | 2013 | 7 | 0.540 |
Why?
| | Liver | 1 | 2026 | 1889 | 0.520 |
Why?
| | Isotope Labeling | 2 | 2009 | 83 | 0.510 |
Why?
| | Ozone | 1 | 2016 | 131 | 0.440 |
Why?
| | Optic Nerve | 1 | 2013 | 67 | 0.400 |
Why?
| | Macrophages, Alveolar | 1 | 2016 | 368 | 0.390 |
Why?
| | para-Aminobenzoates | 2 | 2010 | 8 | 0.380 |
Why?
| | Oxidation-Reduction | 4 | 2024 | 1078 | 0.360 |
Why?
| | Computational Biology | 1 | 2017 | 681 | 0.360 |
Why?
| | Fetal Blood | 2 | 2024 | 325 | 0.340 |
Why?
| | Retina | 1 | 2013 | 319 | 0.330 |
Why?
| | Acrolein | 1 | 2007 | 22 | 0.260 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 581 | 0.250 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2024 | 214 | 0.230 |
Why?
| | Triglycerides | 5 | 2022 | 517 | 0.230 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2026 | 117 | 0.220 |
Why?
| | Glycerylphosphorylcholine | 1 | 2005 | 5 | 0.220 |
Why?
| | Paracrine Communication | 1 | 2025 | 67 | 0.220 |
Why?
| | Diet, High-Fat | 1 | 2026 | 261 | 0.210 |
Why?
| | Methane | 1 | 2005 | 51 | 0.210 |
Why?
| | Free Radicals | 1 | 2005 | 110 | 0.210 |
Why?
| | Diglycerides | 1 | 2024 | 59 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2016 | 96 | 0.200 |
Why?
| | Trophoblasts | 1 | 2026 | 218 | 0.200 |
Why?
| | Lung | 1 | 2017 | 4089 | 0.200 |
Why?
| | Fatty Liver | 1 | 2026 | 250 | 0.200 |
Why?
| | Humans | 26 | 2026 | 144667 | 0.200 |
Why?
| | Female | 16 | 2026 | 78304 | 0.200 |
Why?
| | Symporters | 1 | 2023 | 48 | 0.200 |
Why?
| | Hyperinsulinism | 1 | 2024 | 114 | 0.190 |
Why?
| | Chromatography, Liquid | 3 | 2023 | 444 | 0.190 |
Why?
| | Liposomes | 4 | 2010 | 256 | 0.190 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 92 | 0.190 |
Why?
| | Middle Aged | 6 | 2026 | 35971 | 0.190 |
Why?
| | Animals | 14 | 2026 | 37948 | 0.190 |
Why?
| | Pancreas | 1 | 2025 | 341 | 0.190 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 141 | 0.180 |
Why?
| | Glycerol | 1 | 2022 | 90 | 0.180 |
Why?
| | Oxygen | 2 | 2022 | 984 | 0.180 |
Why?
| | Overnutrition | 1 | 2022 | 28 | 0.180 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2010 | 580 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 100 | 0.170 |
Why?
| | Mass Spectrometry | 1 | 2005 | 743 | 0.170 |
Why?
| | Dietary Supplements | 2 | 2024 | 575 | 0.170 |
Why?
| | Mice | 11 | 2026 | 18261 | 0.170 |
Why?
| | Adult | 6 | 2026 | 40489 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2016 | 231 | 0.160 |
Why?
| | Male | 10 | 2026 | 72431 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 139 | 0.150 |
Why?
| | Heart Diseases | 1 | 2022 | 341 | 0.140 |
Why?
| | Pregnancy | 7 | 2026 | 7122 | 0.140 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1468 | 0.140 |
Why?
| | Rats | 2 | 2024 | 5570 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5870 | 0.140 |
Why?
| | Cell Cycle Proteins | 2 | 2016 | 628 | 0.140 |
Why?
| | Lysophospholipids | 2 | 2008 | 78 | 0.130 |
Why?
| | Arachidonic Acid | 2 | 2009 | 101 | 0.130 |
Why?
| | Insulin | 2 | 2025 | 2502 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2022 | 591 | 0.120 |
Why?
| | Neutrophils | 3 | 2007 | 1118 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3147 | 0.120 |
Why?
| | Biological Transport | 1 | 2017 | 418 | 0.120 |
Why?
| | Body Mass Index | 1 | 2024 | 2419 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 641 | 0.110 |
Why?
| | Molecular Structure | 2 | 2007 | 495 | 0.110 |
Why?
| | Sulfoglycosphingolipids | 1 | 2013 | 3 | 0.100 |
Why?
| | Cell Line | 2 | 2010 | 2821 | 0.100 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2013 | 29 | 0.100 |
Why?
| | Subcutaneous Fat | 2 | 2025 | 79 | 0.100 |
Why?
| | Lysophosphatidylcholines | 2 | 2024 | 23 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 978 | 0.100 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 79 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 280 | 0.100 |
Why?
| | Interferon-gamma | 1 | 2016 | 781 | 0.090 |
Why?
| | Carnitine | 2 | 2024 | 90 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 5967 | 0.090 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 111 | 0.090 |
Why?
| | Sphingolipids | 2 | 2023 | 83 | 0.090 |
Why?
| | Fatty Acids | 2 | 2024 | 454 | 0.080 |
Why?
| | Organ Specificity | 1 | 2011 | 311 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2172 | 0.080 |
Why?
| | 4-Aminobenzoic Acid | 1 | 2009 | 8 | 0.080 |
Why?
| | Eicosanoids | 2 | 2009 | 58 | 0.070 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 17 | 0.070 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2009 | 20 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.070 |
Why?
| | Apolipoproteins E | 1 | 2009 | 93 | 0.070 |
Why?
| | Monoglycerides | 1 | 2008 | 2 | 0.070 |
Why?
| | Fetus | 2 | 2024 | 800 | 0.070 |
Why?
| | Peritonitis | 1 | 2009 | 83 | 0.070 |
Why?
| | Signal Transduction | 2 | 2026 | 5185 | 0.070 |
Why?
| | HL-60 Cells | 1 | 2007 | 29 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2026 | 3109 | 0.070 |
Why?
| | Secretory Vesicles | 1 | 2007 | 24 | 0.060 |
Why?
| | Neutrophil Activation | 1 | 2007 | 84 | 0.060 |
Why?
| | Ionophores | 1 | 2005 | 21 | 0.060 |
Why?
| | Calcimycin | 1 | 2005 | 36 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 409 | 0.060 |
Why?
| | Calcium Signaling | 1 | 2007 | 243 | 0.060 |
Why?
| | Hydrocarbons | 1 | 2005 | 31 | 0.050 |
Why?
| | Models, Molecular | 1 | 2010 | 1610 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 163 | 0.050 |
Why?
| | Membrane Lipids | 1 | 2005 | 82 | 0.050 |
Why?
| | Aldehydes | 1 | 2005 | 141 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 35 | 0.050 |
Why?
| | Glucose Clamp Technique | 1 | 2024 | 199 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 115 | 0.050 |
Why?
| | Choline | 1 | 2024 | 136 | 0.050 |
Why?
| | Models, Chemical | 1 | 2005 | 264 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 178 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 153 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 43 | 0.050 |
Why?
| | Acyltransferases | 1 | 2022 | 78 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 85 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 57 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 27 | 0.050 |
Why?
| | Rheology | 1 | 2022 | 94 | 0.040 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 384 | 0.040 |
Why?
| | Vasodilation | 1 | 2025 | 520 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 144 | 0.040 |
Why?
| | Phosphates | 1 | 2022 | 177 | 0.040 |
Why?
| | Fetal Heart | 1 | 2022 | 56 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 631 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 1029 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8284 | 0.040 |
Why?
| | Cell Membrane | 1 | 2005 | 706 | 0.040 |
Why?
| | PPAR gamma | 1 | 2022 | 177 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 23 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2022 | 174 | 0.040 |
Why?
| | Macrophages | 1 | 2008 | 1496 | 0.040 |
Why?
| | Athletes | 1 | 2024 | 421 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 293 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 221 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2023 | 2815 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 324 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 506 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3523 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 842 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2024 | 586 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 750 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 770 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1207 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 437 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 14122 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1033 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2020 | 498 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2016 | 93 | 0.030 |
Why?
| | Ions | 1 | 2016 | 68 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 915 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7140 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1319 | 0.020 |
Why?
| | Aged | 1 | 2013 | 25955 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2016 | 1154 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2934 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2008 | 4110 | 0.020 |
Why?
| | Peritoneal Lavage | 1 | 2009 | 8 | 0.020 |
Why?
| | Phosphatidylglycerols | 1 | 2008 | 18 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 461 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 268 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 20 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2007 | 69 | 0.020 |
Why?
| | Spleen | 1 | 2009 | 510 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 404 | 0.020 |
Why?
| | Aorta | 1 | 2009 | 427 | 0.010 |
Why?
| | Thromboxanes | 1 | 2005 | 14 | 0.010 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 9 | 0.010 |
Why?
| | Isoprostanes | 1 | 2005 | 15 | 0.010 |
Why?
| | Leukotrienes | 1 | 2005 | 28 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4539 | 0.010 |
Why?
| | Prostaglandins | 1 | 2005 | 94 | 0.010 |
Why?
|
|
Zemski Berry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|